Midwife Licensure Exam Midwifery Pharmacology & Newborn Procedures — Mandated Newborn Procedures by the MidwifeSummary

The Essential Intrapartum and Newborn Care (EINC) protocol defines four time-bound, evidence-based steps that the midwife performs immediately after a normal vaginal delivery: (1) **Immediate and thorough drying** for the first 30 seconds (dry the body and head to prevent heat loss and stimulate breathing; do NOT wipe off vernix); (2) **Early skin-to-skin contact** (place the naked, dried baby prone on the mother's bare abdomen/chest, cover both with a warm dry cloth, and put a bonnet on the baby); (3) **Properly timed cord clamping** (clamp and cut the cord only after cord pulsations stop, typically 1–3 minutes after birth, to allow placental transfusion and improve iron stores); (4) **Non-separation of mother and baby for early breastfeeding** (keep the dyad together, support the baby's crawl to the breast, and facilitate the first latch ideally within the first 90 minutes). These steps are performed in order and are supported by strong evidence for improved neonatal outcomes, reduced hypothermia, better feeding establishment, and enhanced bonding.

The EINC protocol explicitly names practices that should **NOT** be done routinely: (1) **Do NOT suction routinely**—suctioning is only for a baby who is not breathing or has obvious airway obstruction (meconium, secretions blocking the airway); (2) **Do NOT bathe the baby early**—bathing is delayed at least 6 hours and ideally 24 hours to preserve vernix, maintain temperature, and reduce infection risk; (3) **Do NOT separate mother and baby**—separation should be avoided even for 'necessary' procedures; all routine care (examination, weighing, measurement, immunization) can be done with the baby on the mother or immediately after bonding; (4) **Do NOT wipe off vernix**—vernix is protective and hydrating and should be gently rubbed in or left alone; (5) **Do NOT do foot-printing before skin-to-skin**—foot-printing and identification should not disrupt the critical bonding period. These 'nots' are frequently asked as both true/false and scenario-based MLE questions.

If the amniotic fluid is stained with **meconium**, the midwife's response depends on whether the baby is **vigorous** or **not breathing/gasping**: (1) **Vigorous baby** (crying, breathing well, good muscle tone, HR ≥ 100)—proceed with routine EINC, no suctioning, no separation. Meconium alone is not an indication for intervention in a vigorous baby. (2) **Non-breathing or gasping baby**—this is an **emergency**. The midwife **immediately calls for help** (activate emergency response, notify referral facility), clamps and cuts the cord **promptly**, moves the baby to a warm, firm surface, and begins **positioning the head, clearing the airway only if obstructed** (no routine deep suctioning), and initiating **positive-pressure ventilation (PPV) with a bag and mask** within the **'golden minute' (first 60 seconds)** while arranging urgent referral. **Establishing breathing is the single highest priority**—it takes precedence over every routine procedure including cord clamping timing, vitamin K, eye prophylaxis, and weighing. The midwife's role is to recognize the emergency, initiate basic resuscitation, and refer immediately; she does NOT attempt advanced resuscitation beyond bag-and-mask ventilation.

The **APGAR score** (named after Dr. Virginia Apgar) is a **rapid, systematic assessment** of the newborn's transition and physiologic status, scored at **1 minute and again at 5 minutes after birth** (and every 5 minutes up to 20 minutes if depressed). Five signs are assessed, each scored 0, 1, or 2: **Appearance (color)** (0 = blue/pale all over, 1 = body pink with blue extremities, 2 = completely pink), **Pulse (heart rate)** (0 = absent, 1 = < 100/min, 2 = ≥ 100/min), **Grimace (reflex irritability/response)** (0 = no response, 1 = grimace, 2 = cry/cough/sneeze), **Activity (muscle tone)** (0 = limp/flaccid, 1 = some flexion, 2 = active motion), **Respiration** (0 = absent, 1 = slow/irregular/weak cry, 2 = good/strong cry). Total score: **7–10 = normal/good**, **4–6 = moderately depressed** (needs stimulation and close observation), **0–3 = severely depressed** (needs active resuscitation and referral). **Critical point:** APGAR is a **scoring/assessment tool, not a resuscitation trigger**. Resuscitation decisions are based on **breathing, crying, tone, and heart rate** and must begin immediately if the baby is not breathing—the midwife does NOT wait for the 1-minute APGAR score. APGAR at 5 minutes is the best predictor of short-term outcome; low APGAR at 5 minutes indicates need for continued support and/or referral.

The midwife must recognize normal newborn parameters to identify abnormality early. **Respiratory rate (RR):** normal is **40–60 breaths per minute** at rest; below 40 or above 60, or any signs of respiratory distress (grunting, flaring, retractions, cyanosis), is abnormal. **Heart rate (HR):** normal is **120–160 beats per minute**; bradycardia (< 120) or tachycardia (> 160) with poor perfusion requires assessment. **Axillary temperature:** normal is **36.5–37.5 °C**; below 36.5 °C is hypothermia (a common and serious problem in newborns), above 37.5 °C is fever (less common but may indicate infection). **Birth weight:** normal term newborn is **2,500–4,000 grams**; less than 2,500 g is classified as low birth weight (LBW) and requires closer monitoring and possible referral depending on other factors. **Length:** normal term newborn is approximately **50 cm**. **Head circumference:** normal is approximately **32–36 cm**. **Physical findings:** the midwife does a quick **head-to-toe examination** for gross anomalies (cleft lip/palate, spina bifida, limb defects, skin lesions), checks **patency of the anus**, notes **presence of both testes** (or external genitalia assessment), and assesses **reflexes** (suck, rooting, grasp, startle) to rule out major anomalies requiring referral. Milia (small white dots on nose/cheeks), vernix, and lanugo are normal findings.

Newborns lose heat rapidly through **evaporation** (moisture on skin), **conduction** (contact with cold surfaces), **convection** (cold air currents), and **radiation** (to cold surroundings). Hypothermia (core temperature < 36.5 °C) is dangerous and common in resource-limited settings, leading to metabolic acidosis, hypoglycemia, increased oxygen demand, and potentially death. The midwife maintains the **warm chain** through a series of practices: (1) **Dry immediately and thoroughly** (30 seconds) using a pre-warmed cloth; (2) **Skin-to-skin contact** (mother's bare chest/abdomen) with dry cloth cover and bonnet—this is the **gold standard** for warmth and is called **Kangaroo Mother Care (KMC)**; (3) **Bonnet and layers**—keep the head covered and use blankets; (4) **Delayed bathing**—delay at least 6 hours, ideally 24 hours; (5) **Warm, draft-free environment**—maintain room temperature **25–28 °C**; (6) **Warm hands and surfaces**—use pre-warmed examination cloths and surfaces; (7) **Minimize unnecessary exposure**—keep the baby covered during examination. If the baby is hypothermic (temperature < 36.5 °C), the midwife increases skin-to-skin contact, adds more covers, moves to a warmer room, and **re-checks temperature frequently**. Persistent or severe hypothermia (< 35 °C) with poor feeding or lethargy is an emergency and a reason to **refer immediately**. Teach the mother **KMC at home** (24 hours a day if possible) as both warmth and bonding.

Newborns have low vitamin K stores and immature liver synthesis, putting them at risk for **Vitamin K Deficiency Bleeding (VKDB)**, a rare but serious bleeding disorder (classic presentations: hemorrhagic disease of the newborn, cephalohematoma, GI bleed, intracranial hemorrhage). **Every newborn receives a single intramuscular dose of Vitamin K1 (phytomenadione)** as prophylaxis: **1 mg IM for a term or normal-weight baby, or 0.5 mg IM for a preterm or very low-birth-weight (< 1.5 kg) baby**. The injection is given into the **anterolateral thigh (vastus lateralis muscle)** within the **first hour(s) after birth**, after drying, assessment, and skin-to-skin bonding (so as not to interrupt bonding). **Timing note:** Vitamin K is ideally given **before any heel-prick procedures** (newborn screening) to reduce bleeding risk, but it can be given after bonding and breastfeeding initiation if sequencing allows. The dose is critical: **do not give too much** (hepatotoxicity risk in certain conditions) or too little (prophylaxis failure). **Technique:** use a sterile needle (23–25 gauge), clean skin with alcohol, and inject into the muscle belly (not subcutaneously). Discard the needle safely. Teach the mother that vitamin K is standard newborn care and not an 'extra' medication.

**Ophthalmia neonatorum** (newborn conjunctivitis caused by maternal STIs, primarily *Neisseria gonorrhoeae* or *Chlamydia trachomatis*) can cause permanent blindness if untreated. To prevent it, the midwife applies **topical antibiotic prophylaxis to both eyes immediately after birth**. The standard agent in the Philippines is **erythromycin 0.5% ophthalmic ointment** (or tetracycline 1% ointment as alternative). **Technique:** (1) Ensure asepsis and clean hands; (2) Gently open each eyelid by retracting the upper and lower lids; (3) Place a thin ribbon of ointment into the **lower conjunctival sac, from the inner (medial) to the outer (lateral) canthus**—do not apply directly to the cornea; (4) Repeat for the other eye; (5) Do **NOT irrigate the eyes** with water or saline after application (irrigation reduces efficacy); allow ointment to remain. **Timing:** Eye prophylaxis is done **after the first breastfeed or bonding period, ideally within the first hour**, so as not to interrupt skin-to-skin and early feeding. It is a **mandated procedure for every newborn**, regardless of whether the mother reports or denies STI history (because maternal STI status is not always known and vertical transmission can occur). Document that it was done. **Side effect:** mild chemical conjunctivitis (redness, mild discharge) is expected and resolves spontaneously; parent should be warned not to be alarmed.

The **Newborn Screening Act of 2004 (RA 9288)** is a landmark Philippine law mandating **routine newborn screening for all newborns** to detect disorders that cause **mental retardation, disability, or death if untreated but are entirely preventable or treatable with early intervention**. **Principle:** Screen early (before symptoms appear) to allow prompt treatment and prevent irreversible damage. **Method:** **Capillary heel-prick blood** collected onto a special **filter-paper card (Guthrie card)**, usually collected by the midwife or nurse. **Timing:** **Ideal is 24 to 72 hours after birth**. **Critical rule:** Do NOT collect before 24 hours (risk of false results, especially for 17-OHP/congenital adrenal hyperplasia). If the baby must be discharged earlier (before 24 h), it may be collected at 24 hours if still in facility, but if unavoidable collection occurs before 24 h, **a repeat sample is required by 2 weeks of age**. **Legal responsibility:** The **midwife/birth attendant is legally responsible** for ensuring the sample is taken, documented, and submitted to the screening laboratory. She must also **inform the parents** of the availability of screening and its benefits; parents may refuse only after being fully informed, and refusal must be documented. **Expanded Newborn Screening Panel (ENBS):** The panel screens for multiple disorders grouped by consequence: (1) **Congenital hypothyroidism (CH)** — classical example: untreated causes severe intellectual disability, but early thyroxine replacement allows normal development; screened via TSH and free T4; (2) **Congenital adrenal hyperplasia (CAH)** — screened via 17-hydroxyprogesterone (17-OHP); (3) **Galactosemia (GAL)** — inability to metabolize galactose, causing intellectual disability and cataracts; screened via galactose and GALT enzyme; (4) **Phenylketonuria (PKU)** — inability to metabolize phenylalanine, causing intellectual disability; treated with phenylalanine-restricted diet; (5) **Glucose-6-phosphate dehydrogenase deficiency (G6PD)** — hemolytic anemia triggered by fava beans or certain drugs; screened and parents counseled; (6) **Maple syrup urine disease (MSUD)** — rare but severe metabolic disorder. Many programs now include **hemoglobinopathies, biotinidase deficiency, and cystic fibrosis**. **Results and follow-up:** (1) **Normal/low-risk result**—routine follow-up; (2) **High-risk/positive result**—**urgent referral** for confirmatory testing and specialist evaluation; parents are contacted immediately. False positives occur (especially in preterm, sick, or transfused babies) and confirmatory testing differentiates true positives from false alarms. **Documentation:** The midwife documents in the infant's record that screening was performed, the date, result status (when received), and parental education. **Congenital hypothyroidism** is the most frequently tested high-yield example: teach students that **undetected CH = permanent intellectual disability, but early thyroxine = normal life**.

The **Universal Newborn Hearing Screening and Intervention Act of 2009 (RA 9709)** mandates **hearing screening for every newborn**, ideally **before discharge from the birthing facility or within the first month (no later than 3 months)**. **Principle:** Congenital hearing loss, if undetected, leads to permanent speech and language developmental delay, affecting the child's education and social integration. Early detection (by 3 months) and early intervention (hearing aids, cochlear implants, sign language education) by 6 months allows normal speech and language development. **Methods:** Screening uses **otoacoustic emissions (OAE)** and/or **automated auditory brainstem response (AABR)**—both are **non-invasive, painless, quick (5–10 minutes), and can be done while the baby sleeps**. **OAE** measures sounds produced by the inner ear in response to clicks; **AABR** measures electrical brain responses to sound. Both are objective and do not require behavioral response. **Timing and accessibility:** (1) If screening equipment is available at the BHS/facility, the midwife may conduct screening or refer to trained personnel; (2) If equipment is NOT available, the midwife **refers the newborn to a designated screening facility** (tertiary hospital, audiology center) and **documents the referral**; (3) Screening should be done before discharge, but if not, it must be completed by 1 month (latest 3 months). **Result interpretation:** (1) **Pass (normal)** — screening complete, no action needed unless risk factors present (e.g., family history, prematurity, infection); (2) **Refer (abnormal)** — result is inconclusive; baby needs **repeat screening or confirmatory testing** (ABR, tympanometry) at a specialist center. **Critical:** A 'refer' result does **NOT** mean the baby has confirmed hearing loss—it means further testing is needed. Do NOT alarm the parents; explain that repeat testing will clarify. **Follow-up:** The midwife ensures the parents understand the result, keep referral appointments, and return for confirmatory testing. **Documentation:** Record screening results and any referral in the baby's health record. **Risk factors:** Newborns with risk factors (prematurity, low birth weight, TORCH infections, congenital anomalies, family history, perinatal complications) may need more frequent monitoring even if initial screening is normal.

After the umbilical cord is properly clamped (between two clamps/ties) and cut with a **sterile blade or scissors** (between the clamps), the midwife performs **cord care**. **Modern, evidence-based cord care in the Philippines follows DRY CORD CARE:** Keep the stump **clean and dry**; **apply nothing** to the cord (no alcohol, no antiseptic creams, no traditional 'pusod' (navel) preparations, no dressings) unless local protocol specifically mandates **chlorhexidine 7.1% solution** in high-risk settings (which is less common in community BHS). The rationale: Dry cord care reduces infection risk (omphalitis) better than wet cord care or application of substances. **Practical steps:** (1) After cutting, fold or roll the **diaper down below the cord** to expose it to air; (2) Teach the mother to keep it **clean and dry**; (3) If the cord becomes soiled (urine, feces), gently wipe with a clean cloth and allow to air-dry; (4) **Avoid bathing** the baby (or at least avoid wetting the cord area) until the stump has separated; (5) **Watch for danger signs** of **omphalitis** (cord infection): redness around the cord, foul-smelling or purulent discharge, swelling of the abdomen, fever in the baby, or lethargy. If omphalitis is suspected, **refer immediately**. **Timeline:** The umbilical cord stump typically separates in **5–15 days**; it may take up to 3 weeks. **After separation:** A small amount of serous or blood-tinged discharge is normal for a few days; teach the mother to continue keeping it dry and watch for signs of infection at the navel site (granulation tissue, bleeding, pus). The navel heals completely by **3–4 weeks**. **Documentation:** Record cord care instructions given to the mother in the health record.

The Philippine vaccination schedule mandates two vaccines at birth: **BCG (Bacille Calmette-Guérin)** and **Hepatitis B (HBV)**, both given **within 24 hours of birth**. These are part of the **mandated newborn package** and are the midwife's responsibility to facilitate, either by giving them herself (if trained) or ensuring they are given promptly by the health facility. **BCG vaccine:** (1) **Indication:** Prevention of tuberculosis (TB), especially severe TB (TB meningitis, TB disease in infants); (2) **Dose:** **0.05 mL IM for newborns** (different from older children and adults); (3) **Site:** Intradermal injection into the **upper arm (deltoid region)**, just below the shoulder; (4) **Timing:** Within 24 hours of birth, preferably before discharge; (5) **Side effects:** Local reaction (induration, pustule, later a scar) is **expected and normal**; systemic side effects are rare; the scar is permanent; teach parents not to treat the reaction. **Hepatitis B vaccine:** (1) **Indication:** Prevention of hepatitis B infection (a blood-borne virus causing chronic liver disease, cirrhosis, hepatocellular carcinoma); birth dose protects against vertical transmission (mother-to-baby) and early infection; (2) **Dose:** **0.5 mL IM** for newborns; (3) **Site:** Anterolateral thigh (vastus lateralis), same area as vitamin K; can be given at the same time (different syringes, different sites); (4) **Timing:** Within 24 hours of birth, ideally before discharge; (5) **Schedule:** This is the first of three doses (birth, 1–2 months, 6 months); ensure the mother has the schedule and returns for subsequent doses. **Administration:** Use sterile technique, asepsis, appropriate needle gauge (23–25 for IM), and safe disposal. **Documentation:** Record vaccine name, dose, date, time, site, lot number, and expiration date in the infant's vaccination record (health card or facility record). **Counseling:** Teach the mother the importance of both vaccines, the expected side effects (especially BCG scar), and the need for subsequent doses. Emphasize that hepatitis B birth dose is critical for babies born to HBsAg-positive mothers.

The midwife must perform many procedures in the first hours of life, but **sequencing and prioritization are critical**. The order is based on **urgency and preservation of normal physiologic processes** (especially bonding and breastfeeding). Here is the evidence-based sequence: **(1) IMMEDIATE (first 30 seconds to 5 minutes):** Assess breathing, heart rate, tone, and presence of gross anomalies (does NOT require separation). Dry thoroughly. If the baby is NOT breathing or gasping, **immediately call for help and begin resuscitation; refer urgently. Do not proceed with other procedures.** (2) EARLY (first 30 minutes to 90 minutes):** Skin-to-skin contact with the mother (bonding, warmth, stimulation of breastfeeding). Support early breastfeeding (within 90 minutes). Clamp and cut the cord (at 1–3 minutes after pulsations stop). Assign APGAR scores at 1 and 5 minutes. Perform basic newborn examination (listening to heart/lungs, palpating abdomen, checking anus patency, assessing reflexes) while baby is on mother or immediately after. (3) NEXT (first hour to several hours):** After bonding and first breastfeed, perform injections: **Vitamin K1 IM (first hour)**, **eye prophylaxis (erythromycin ointment—after breastfeed, within 1 hour)**, **immunizations (BCG and Hepatitis B within 24 hours)**. (4) ROUTINE (first few hours to 24 hours):** Weigh and measure the baby (length, head circumference, chest circumference). Full physical examination (including skin, external genitalia, musculoskeletal exam for limb defects). Temperature monitoring. Feeding assessment and support. Cord care instruction. (5) NEWBORN SCREENING (24–72 hours):** Heel-prick capillary blood collection for newborn screening (RA 9288). **Hearing screening (before discharge/within 1 month—RA 9709).** **Guiding principle:** A **warm, breathing, bonding, breastfeeding baby takes precedence over every routine procedure.** If the baby is not breathing, the midwife does NOT worry about vitamin K, eye prophylaxis, weighing, or umbilical cord blood banking—she focuses on establishing breathing and referring. If the baby is hypothermic, the midwife does NOT delay rewarming to complete other procedures. **Non-separation:** Throughout this sequence, the midwife minimizes separation of mother and baby. Weighing, measurement, examination, and injections can be done with the baby on the mother (or in immediate skin-to-skin) or immediately after bonding. Many procedures can be done simultaneously or in quick succession to minimize disruption.

The midwife's scope under RA 7392 is to provide care for **NORMAL maternal, newborn, and family-planning care**—and to **recognize and refer complications and high-risk situations**. She is NOT an acute-care provider; her role is early detection and timely referral. **High-risk newborn scenarios requiring immediate or urgent referral include:** (1) **Non-breathing or gasping baby**—call for help, begin bag-and-mask ventilation if trained, refer immediately to BEmONC facility; (2) **APGAR 0–3 (severely depressed) at 5 minutes**—resuscitate and refer urgently; (3) **Meconium-stained baby with respiratory distress**—observe closely for meconium aspiration syndrome (grunting, cyanosis, retractions) and refer if present; (4) **Cyanosis (central, not just peripheral/acrocyanosis)**—sign of respiratory or cardiac disease; refer; (5) **Persistent tachypnea (RR > 60 at rest)**—may indicate respiratory distress or infection; refer for chest X-ray and evaluation; (6) **Severe hypothermia (< 35 °C) not responding to warming**—medical emergency; refer to warm, intensive setting; (7) **Hypoglycemia (if tested and confirmed)**—treat with dextrose/feeding and refer if refractory; (8) **Jaundice within 24 hours of birth (pathologic jaundice)**—always refer; may indicate hemolytic disease or infection; (9) **Gross congenital anomalies** (cleft palate, spina bifida, limb defects, abdominal wall defects, congenital heart disease signs)—refer for evaluation and surgical planning; (10) **Signs of infection:** fever (temp > 38 °C), poor feeding, lethargy, irritability, pustules, omphalitis, conjunctivitis with purulent discharge (not chemical from erythromycin); refer for culture and antibiotics; (11) **Seizures, abnormal movements, or altered consciousness**—refer urgently; (12) **Asymmetry or injury from delivery** (fractured clavicle, brachial plexus injury, facial nerve palsy, cephalohematoma, caput succedaneum)—assess and refer as needed; many resolve spontaneously but require monitoring; (13) **Mother with positive VDL (syphilis), positive HBsAg (hepatitis B), positive HIV, or active TB**—newborn requires specific management/monitoring; refer or ensure coordination with specialist. **Midwife's role in referral:** (1) **Assess and stabilize**—perform basic resuscitation (position, airway clearance, PPV) if indicated; keep baby warm; initiate IV access if needed for fluids/medications if within scope; (2) **Communicate clearly**—describe findings to receiving facility in simple, objective terms (not diagnoses, unless midwife is trained); example: 'Baby not breathing at delivery, began bag-and-mask ventilation, APGAR was 2 at 1 minute, now breathing with support, HR 90, still cyanotic'—avoid 'asphyxia' or 'birth asphyxia' as diagnosis unless formally trained; (3) **Arrange transport**—call for ambulance, ensure emergency facility is ready, accompany the baby if possible; (4) **Document**—record findings, actions taken, time of referral, and recipient's name in the health record; (5) **Support the family**—explain why referral is necessary, answer questions simply and honestly, and encourage the mother/parents to accompany the baby. **When the midwife is in doubt, refer**—erring on the side of caution is appropriate. A healthy term newborn suspected of nothing serious can always be returned home after evaluation; a sick newborn not referred may die.

The four EINC steps (dry, skin-to-skin, delayed cord clamping, non-separation) are **designed to facilitate early breastfeeding and bonding**. Skin-to-skin contact stimulates the baby's crawl-to-breast reflex and the mother's milk letdown; non-separation ensures the baby reaches the breast within 90 minutes when both are most alert. Early breastfeeding (colostrum) provides immune factors (IgA, white blood cells) and establishes latch. Delayed cord clamping improves the baby's iron and blood volume, supporting oxygen delivery during the transition to air breathing. All EINC steps work synergistically to support normal newborn physiology and breastfeeding success.

Both vitamin K (VKDB prevention) and eye prophylaxis (ophthalmia neonatorum prevention) are **prophylactic medications**—they are given to **healthy newborns to prevent rare but serious complications** from vertical transmission (maternal blood, maternal STI) or deficiency. Both are administered early (within first hour(s)) after drying and bonding. Together, they represent the midwife's role in **primary prevention and reduction of preventable newborn morbidity**.

Newborn screening (RA 9288) and hearing screening (RA 9709) are **early detection programs** that operate on the principle that **early identification of serious disorders allows early, preventive treatment**. Congenital hypothyroidism, for example, is undetectable by clinical exam in the newborn period but screening at 24–72 hours allows thyroxine replacement before developmental damage occurs. Similarly, congenital hearing loss is not clinically obvious at birth but early detection by 3 months allows intervention by 6 months, preserving speech development. Both laws (RA 9288, RA 9709) assign **legal responsibility to the birth attendant (midwife)** to ensure screening is done and results are followed. These are examples of **secondary prevention (early detection of disease before symptoms appear)** and are central to the midwife's role in harm reduction and maternal-child health.

Thermoregulation (maintaining normal temperature 36.5–37.5 °C) is **essential for newborn survival** because hypothermia (< 36.5 °C) leads to: metabolic acidosis, hypoglycemia (increased glucose consumption for warmth), vasoconstriction (poor perfusion), respiratory depression, and increased oxygen demand—a cascade that can be fatal. The **warm chain** (drying, skin-to-skin, bonnet, warm room, delayed bathing) is the midwife's primary defense against hypothermia. KMC (Kangaroo Mother Care—skin-to-skin at home) is also the **most effective and accessible intervention for low-birth-weight babies** and prevents hypothermia, improves feeding, and reduces infection. Thermoregulation is thus linked to **every other newborn care goal: breathing (oxygen demand), breastfeeding (poor perfusion impairs feeding), and infection prevention (hypothermia impairs immunity).**

The **correct sequencing and prioritization of newborn procedures** reflect the midwife's **scope and philosophy**: she is a **primary provider of NORMAL care and an early-detection specialist for complications**. She does NOT delay resuscitation to complete routine procedures (vitamin K, eye prophylaxis), nor does she separate mother and baby unnecessarily to accomplish tasks. Instead, she sequences procedures to **maximize safety, minimize separation, support bonding and breastfeeding, and flag high-risk situations early for referral**. This is the essence of **midwifery-centered, physiologic newborn care** in the Philippine context (RHU, BHS, lying-in) where resources are limited and mothers expect continuity and partnership.

All the procedures in this chapter—cord care, vitamin K, eye prophylaxis, newborn screening, hearing screening, immunization—are **mandated by Philippine law (RA 7392, RA 9288, RA 9709, and DOH policies)**. The midwife's **legal and ethical responsibility** is to perform them correctly, document them, inform parents, and ensure follow-up. She is **accountable** for adherence to these standards. The MLE tests both **clinical knowledge** (how to do it correctly) and **professional accountability** (knowing it's required by law, documenting it, informing parents). This underpins the midwife's role as a **regulated professional** in the Philippine healthcare system.